Company

IMUTEX Ltd

Pharmaceutical Manufacturing United Kingdom 2 employees

Employees: 2
Contacts: 2
Emails: 2
Phones: 1

imutex.com LinkedIn Crunchbase

IMUTEX Ltd Overview

Headquarters: United Kingdom
Phone Number: Available in AeroLeads
Website: imutex.com
Industry: Pharmaceutical Manufacturing
Employees: 2
Founded: 2016
Funding: 20.5M
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

European Green Transition

About IMUTEX Ltd

Imutex Limited, formed in 2016, is a joint venture between SEEK Group and hVIVO, part of Open Orphan plc, to accelerate the development of a Broad-Spectrum ‘Universal’ Influenza Vaccine, FLU-v, and a Mosquito-Borne Diseases Vaccine, AGS-v. The development of the FLU-v Universal Flu Vaccine and the AGS-v Mosquito-Borne Diseases vaccines are key public health priorities identified by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) in the United States. Imutex is collaborating with the National Institute of Allergy and Infectious Diseases (NIAID) to accelerate development of both vaccines.

IMUTEX Ltd Contact Details

People in AeroLeads: 2
With contact data: 2
Email contacts: 2; 100.0% coverage
Phone contacts: 1; 50.0% coverage

IMUTEX Ltd Org Chart

Sample employees and titles

Name	Title	Location	Contact
Cathal Friel	Dublin, London & Vienna, Chairman and Co-founder at Open Orphan Plc (Now Hvivo Plc) & Poolbeg Pharma Plc, Co-founder & Director at Euro Green	Greater Dublin, Ireland	Email Phone
Kimbell Duncan	Chief Executive Officer at Conserv Bioscience	Switzerland	Email